Emerging Oncology Insights - GP Webinar
This educational webinar brings together three expert-led sessions designed to support GPs in navigating key areas of cancer genetics, haematology, and endocrinology. Each presentation offers practical, clinically relevant guidance to enhance confidence in early detection, appropriate investigation, and effective shared care.
Date: Wednesday 29 April 2026
Time: 6:30pm - 8:00pm
Location: Online webinar via MEDD
Program
Facilitated by:
ClinProf Gavin Marx - Medical Oncologist
Clinical Director of the San Integrated Cancer Centre
All in the family: When to offer genetic testing.
Dr Hilda High - Genetic Oncologist
Medicare funded testing is now available for all patients diagnosed with breast cancer at or before age 50, regardless of their current age. Doctors are being sued for NOT recommending genetic testing, even in patients who have not had cancer. This simple to understand presentation explains how to quickly and easily determine which individuals should have genetic testing based on their personal and/or family history. Links to resources, including patient information videos and handouts, will also be provided.
What’s new in diffuse large cell lymphoma?
Dr Stephanie Hayes - Specialist Haematologist
In this session, Dr Stephanie Hayes will provide an update on the evolving landscape of diagnosis and management of diffuse large B-cell lymphoma. The presentation will review key presenting features seen in general practice, current diagnostic pathways, and recent advances in treatment including targeted therapies and immunotherapy. The session will also highlight the GP’s role in early detection, referral, and ongoing shared care of patients undergoing treatment.
Thyroid cancer in primary care: A practical guide and relevant updates from the 2025 ATA guidelines for differentiated thyroid cancer.
Dr Jingyi Cao - Head and Neck Surgeon, Surgical Oncologist
Thyroid nodules are common in general practice, and while the majority are benign, identifying the small proportion that represent thyroid cancer is essential. During this session, GPs will learn about a practical overview of the assessment and initial management of thyroid nodules, including when to investigate, when to biopsy, and when referral is indicated. Recent updates in thyroid cancer management, including risk-adapted surgery and active surveillance for selected low-risk cancers, will also be discussed.